MEROPENEM Labatec 500 mg i.v. flac 10 pce
7680594630017
CH-59463
J01DH02
08.01.25
Reimbursement limitations:
MERONEM
Mucoviscidose
1 / 3
google
Details
- Product number
- 5946301
- CPT
- -
- Packaging group
- 10 x 500
- Unit
- mg
- Composition
- Praeparatio sicca: meropenemum 500 mg ut meropenemum trihydricum, natrii carbonas corresp. natrium 45.1 mg pro vitro.
Articles (1)
Meropenem Labatec i.v. 500 mg, poudre pour injection ou perfusion
poudre pour injection ou perfusion
10 x 500
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRS
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRS
|
- | Substance | WIZUS |
|
PRS
|
- | Substance | HNIDK |
|
PRS
|
45.1 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 137.90
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/08/2010
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 59463
- Drug name
- Meropenem Labatec i.v., poudre pour injection ou perfusion
- Galenic form
- PULPA
- ATC Code
- J01DH02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 18/12/2009
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.25
- Domain
- Human medicine
Packaging details
- Description (FR)
- MEROPENEM Labatec 500 mg i.v. flac 10 pce
- Description (DE)
- MEROPENEM Labatec 500 mg i.v. Durchstf 10 Stk
- Market launch
- 18/12/2009
- Narcotic (BTM)
- No